Valacyclovir 1000 MG Oral Tablet [Valtrex] — RxCUI 212448
RxNorm drug concept · Semantic branded drug
RxCUI 212448
Semantic branded drug · SBD
● Current RxNorm concept 3 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI212448
Official nameValacyclovir 1000 MG Oral Tablet [Valtrex]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asValtrex 1 GM Oral Tablet; Valtrex (as valacyclovir hydrochloride) 1000 MG Oral Tablet; Valtrex 1000 MG Oral Tablet
FDA products mapped3
Package NDCs mapped6
Reported Medicaid activity (SDUD)276 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Valacyclovir: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Unfortunately, no — valacyclovir controls the virus but doesn't eliminate it from your body. The herpes virus stays dormant in your nerve cells after the infection. What valacyclov...
- Can valacyclovir cure my herpes infection for good?
- The sooner the better — really. For cold sores, you should start at the very first tingle, itch, or burning sensation, before a blister even forms. For genital herpes outbreaks, st...
- When should I start taking it during an outbreak?
🕸️ Concept Web — How Valacyclovir 1000 MG Oral Tablet [Valtrex] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Valacyclovir 1000 MG Oral Tablet [Valtrex]
RxCUI 212448 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Valacyclovir
73645IN
-
Valacyclovir
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Valtrex
152490BN
-
Valtrex
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Valacyclovir Oral Tablet
374272SCDF -
Valacyclovir Oral Product
1163984SCDG -
Valacyclovir Pill
1163985SCDG -
Valacyclovir Oral Tablet [Valtrex]
368381SBDF -
Valtrex Oral Product
1187342SBDG -
Valtrex Pill
1187343SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Valacyclovir Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Valacyclovir 1000 MG Oral Tablet
313564SCD -
Valacyclovir 1000 MG
330296SCDC -
Valacyclovir 1000 MG [Valtrex]
572631SBDC
-
Valacyclovir 1000 MG Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Valacyclovir 1000 MG Oral Tablet
SCD · 313564 -
Valacyclovir 1000 MG
SCDC · 330296 -
Valacyclovir Oral Tablet
SCDF · 374272 -
Valacyclovir Oral Product
SCDG · 1163984 -
Valacyclovir Pill
SCDG · 1163985
Brand-Name Concepts
-
Valacyclovir 1000 MG [Valtrex]
SBDC · 572631 -
Valacyclovir Oral Tablet [Valtrex]
SBDF · 368381 -
Valtrex Oral Product
SBDG · 1187342 -
Valtrex Pill
SBDG · 1187343 -
Valtrex
BN · 152490
📦 FDA Products & Package NDCs
3 products · 6 package NDCs
6 package NDCs map to RxCUI 212448 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00173-0565-04 | 30 TABLET, FILM COATED in 1 BOTTLE (0173-0565-04) | VALTREX | GlaxoSmithKline LLC | 2002-08-12 |
| 00173-0565-10 | 90 TABLET, FILM COATED in 1 BOTTLE (0173-0565-10) | VALTREX | GlaxoSmithKline LLC | 2002-08-12 |
| 00173-0933-08 | 30 TABLET, FILM COATED in 1 BOTTLE (0173-0933-08) | VALTREX | GlaxoSmithKline LLC | 1995-08-01 |
| 00173-0933-10 | 90 TABLET, FILM COATED in 1 BOTTLE (0173-0933-10) | VALTREX | GlaxoSmithKline LLC | 1995-08-01 |
| 70518-2039-01 | 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2039-1) | VALTREX | REMEDYREPACK INC. | 2023-07-17 |
| 70518-2039-02 | 5 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-2039-2) | VALTREX | REMEDYREPACK INC. | 2023-10-02 |
Observed labelers:
GlaxoSmithKline LLC (4) ·
REMEDYREPACK INC. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.